title: Abiraterone acetate: a hat trick of clinical benefits.
authors.affiliation: Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Schweizer
authors.forename: Emmanuel S
authors.initials: ES
authors.lastname: Antonarakis
mesh_terms: D000069501:Abiraterone Acetate; D000726:Androgen Antagonists / Q000008:administration & dosage*; D000730:Androstadienes / Q000008:administration & dosage*; D001859:Bone Neoplasms / Q000150:complications* / Q000556:secondary*; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D059408:Pain Management; D011241:Prednisone / Q000008:administration & dosage*; D011471:Prostatic Neoplasms / Q000473:pathology*; D013254:Steroid 17-alpha-Hydroxylase / Q000037:antagonists & inhibitors*
chemical_list: D000726:Androgen Antagonists; D000730:Androstadienes; D005938:Glucocorticoids; D013254:Steroid 17-alpha-Hydroxylase; D000069501:Abiraterone Acetate; D011241:Prednisone